Aspa Therapeutics, a BridgeBio company, shared additional encouraging data from the CANaspire gene therapy trial during an invited presentation at the 26th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT). Read more here.
To view our short video about the basics of genetic screening, and the importance of screening before conception, click here.
